0001192482-19-000170.txt : 20190327 0001192482-19-000170.hdr.sgml : 20190327 20190327174436 ACCESSION NUMBER: 0001192482-19-000170 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190325 FILED AS OF DATE: 20190327 DATE AS OF CHANGE: 20190327 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Ajdler Arnaud CENTRAL INDEX KEY: 0001293424 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36329 FILM NUMBER: 19709287 MAIL ADDRESS: STREET 1: ARPEGGIO ACQUISITION CORPORATION STREET 2: 10 EAST 53RD STREET, 36TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Recro Pharma, Inc. CENTRAL INDEX KEY: 0001588972 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 261523233 STATE OF INCORPORATION: PA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 BUSINESS PHONE: (484) 395-2400 MAIL ADDRESS: STREET 1: 490 LAPP ROAD CITY: MALVERN STATE: PA ZIP: 19355 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2019-03-25 0001588972 Recro Pharma, Inc. REPH 0001293424 Ajdler Arnaud C/O RECRO PHARMA, INC. 490 LAPP ROAD MALVERN PA 19355 1 0 0 0 Stock Option (right to buy) 6.41 2019-03-25 4 A 0 20000 0 A 2029-03-25 Common Stock 20000 20000 D The option vests in three equal installments on March 25, 2020, 2021 and 2022. /s/ Ryan Lake, Attorney-in-fact 2019-03-27